News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
42,309 Results
Type
Article (2947)
Company Profile (45)
Press Release (39316)
Multimedia
Podcasts (16)
Webinars (2)
Section
Business (14691)
Career Advice (101)
Deals (2239)
Drug Delivery (17)
Drug Development (4354)
Employer Resources (23)
FDA (543)
Job Trends (882)
News (21241)
Policy (1192)
Tag
Academia (152)
Accelerated approval (2)
Adcomms (1)
Allergies (7)
Alliances (3615)
ALS (6)
Alzheimer's disease (65)
Antibody-drug conjugate (ADC) (29)
Approvals (515)
Artificial intelligence (39)
Autoimmune disease (13)
Automation (2)
Bankruptcy (13)
Best Places to Work (542)
BIOSECURE Act (4)
Biosimilars (16)
Biotechnology (29)
Bladder cancer (9)
Brain cancer (8)
Breast cancer (49)
Cancer (344)
Cardiovascular disease (11)
Career advice (87)
Career pathing (2)
CAR-T (36)
CDC (6)
Cell therapy (96)
Cervical cancer (2)
Clinical research (3586)
Collaboration (208)
Company closure (2)
Compensation (105)
Complete response letters (3)
COVID-19 (214)
CRISPR (11)
C-suite (116)
Cystic fibrosis (7)
Data (436)
Denatured (8)
Depression (14)
Diabetes (17)
Diagnostics (537)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (5)
Drug discovery (39)
Drug pricing (20)
Drug shortages (1)
Duchenne muscular dystrophy (50)
Earnings (4705)
Editorial (16)
Employer branding (1)
Employer resources (16)
Events (6603)
Executive appointments (138)
FDA (696)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (180)
Gene editing (32)
Generative AI (3)
Gene therapy (74)
GLP-1 (74)
Government (214)
Guidances (27)
Healthcare (797)
HIV (3)
Huntington's disease (6)
IgA nephropathy (12)
Immunology and inflammation (37)
Immuno-oncology (14)
Indications (5)
Infectious disease (232)
Inflammatory bowel disease (16)
Inflation Reduction Act (7)
Influenza (9)
Intellectual property (26)
Interviews (12)
IPO (1070)
IRA (7)
Job creations (319)
Job search strategy (76)
JPM (14)
Kidney cancer (6)
Labor market (23)
Layoffs (58)
Leadership (5)
Legal (229)
Liver cancer (6)
Longevity (1)
Lung cancer (30)
Lymphoma (13)
Machine learning (3)
Management (8)
Manufacturing (60)
MASH (14)
Medical device (388)
Medtech (391)
Mergers & acquisitions (1298)
Metabolic disorders (83)
Multiple sclerosis (24)
Neurodegenerative disease (32)
Neuropsychiatric disorders (15)
Neuroscience (182)
Neurotech (1)
NextGen: Class of 2026 (385)
Non-profit (169)
Now hiring (11)
Obesity (42)
Opinion (30)
Ovarian cancer (18)
Pain (25)
Pancreatic cancer (22)
Parkinson's disease (11)
Partnered (7)
Patents (53)
Patient recruitment (28)
Peanut (1)
People (6017)
Pharmaceutical (6)
Phase 1 (1536)
Phase 2 (1758)
Phase 3 (967)
Pipeline (433)
Policy (44)
Postmarket research (39)
Preclinical (650)
Press Release (2)
Prostate cancer (7)
Psychedelics (9)
Radiopharmaceuticals (19)
Rare diseases (74)
Real estate (434)
Recruiting (7)
Regulatory (1031)
Reports (13)
Research institute (155)
Resumes & cover letters (13)
Rett syndrome (4)
RNA editing (5)
RSV (2)
Schizophrenia (18)
Series A (46)
Series B (23)
Service/supplier (2)
Sickle cell disease (5)
Special edition (3)
Spinal muscular atrophy (3)
Sponsored (2)
Startups (510)
Stomach cancer (2)
Supply chain (6)
Tariffs (8)
The Weekly (8)
Vaccines (74)
Venture capital (23)
Weight loss (27)
Women's health (11)
Worklife (4)
Date
Today (8)
Last 7 days (55)
Last 30 days (175)
Last 365 days (2602)
2026 (296)
2025 (2590)
2024 (2719)
2023 (2975)
2022 (3953)
2021 (4226)
2020 (3657)
2019 (2249)
2018 (1693)
2017 (1880)
2016 (1731)
2015 (1941)
2014 (1447)
2013 (1240)
2012 (1439)
2011 (1405)
2010 (1246)
Location
Africa (52)
Alabama (3)
Arizona (19)
Asia (2060)
Australia (342)
California (1639)
Canada (267)
China (88)
Colorado (55)
Connecticut (24)
Delaware (6)
Europe (4269)
Florida (75)
Georgia (12)
Hawaii (2)
Idaho (3)
Illinois (23)
India (3)
Indiana (64)
Japan (18)
Kansas (14)
Kentucky (1)
Maryland (51)
Massachusetts (591)
Michigan (15)
Minnesota (22)
Mississippi (2)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (144)
New York (90)
North Carolina (138)
Northern California (805)
Ohio (46)
Oklahoma (2)
Oregon (7)
Pennsylvania (114)
Puerto Rico (1)
Rhode Island (3)
South America (53)
South Carolina (1)
Southern California (661)
Tennessee (6)
Texas (160)
United States (3329)
Utah (6)
Virginia (12)
Washington D.C. (3)
Washington State (97)
West Virginia (1)
Wisconsin (13)
42,309 Results for "senti biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Senti Biosciences Completes Enrollment in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)
February 11, 2026
·
8 min read
Press Releases
Senti Biosciences Selected for On-Stage Presentation at Healthcare Conference Taipei 2026
February 4, 2026
·
3 min read
Press Releases
Senti Biosciences Announces New Employment Inducement Grants - December 18, 2025
December 19, 2025
·
2 min read
Press Releases
Senti Biosciences Participates in Virtual Investor CEO Connect Segment to Discuss the Company’s Groundbreaking AML Data at the American Society of Hematology Annual Meeting and Recently Granted RMAT Designation
January 15, 2026
·
2 min read
Press Releases
Senti Bio Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for SENTI-202 in the Treatment of Adults with Relapsed or Refractory Acute Myeloid Leukemia
December 10, 2025
·
10 min read
Press Releases
Senti Bio to Participate in Panel Presentation at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference
January 9, 2026
·
3 min read
Press Releases
Senti Bio to Present at BioJapan
October 7, 2025
·
2 min read
Press Releases
Senti Bio Announces Updated SENTI-202 Clinical Data from Ongoing Phase 1 Trial in Relapsed or Refractory Acute Myeloid Leukemia Patients, Demonstrating Deep, MRD Negative, Durable Complete Remissions and a Favorable Safety Profile
December 10, 2025
·
14 min read
Press Releases
Senti Bio to Host Conference Call and Webcast to Discuss SENTI-202 Clinical Data Being Presented at the American Society of Hematology (ASH) Annual Meeting 2025 on Tuesday, December 9th at 8:00 AM ET
December 4, 2025
·
7 min read
Press Releases
Senti Biosciences to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
August 15, 2025
·
3 min read
1 of 4,231
Next
